BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 2964038)

  • 1. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
    Horstmann RD; Sievertsen HJ; Knobloch J; Fischetti VA
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1657-61. PubMed ID: 2964038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding.
    Kotarsky H; Gustafsson M; Svensson HG; Zipfel PF; Truedsson L; Sjöbring U
    Mol Microbiol; 2001 Aug; 41(4):817-26. PubMed ID: 11532146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
    Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
    J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
    Reuter M; Caswell CC; Lukomski S; Zipfel PF
    J Biol Chem; 2010 Dec; 285(49):38473-85. PubMed ID: 20855886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fibrinogen in complement inhibition by streptococcal M protein.
    Horstmann RD; Sievertsen HJ; Leippe M; Fischetti VA
    Infect Immun; 1992 Dec; 60(12):5036-41. PubMed ID: 1452335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C; Kingzette M; Gewurz H
    J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
    Pandiripally V; Gregory E; Cue D
    Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species specificity of recognition by the alternative pathway of complement.
    Horstmann RD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
    Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the alternative pathway of human complement by C1q.
    Fishelson Z; Müller-Eberhard HJ
    Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.